During the endoderm differentiation of F9 mouse embryonal carcinoma cells,
as induced by sodium butyrate (NaBu) or retinoic acid (RA), gene expression
s of alkaline phosphatase (AL-Pase), pyruvate kinase (PKase) and 5' ribonuc
leotide phosphohydrolase (5'-Nase) were examined. The specific activity of
ALPase was found to increase by 3.5-fold after 48 hr treatment with NaBu. I
n contrast, specific activity of PKase were decreased by 63%. Northern blot
analysis revealed that the elevation of ALPase activity resulted from an i
ncrease in the level of liver/bone/kidney (L/B/K)-type ALPase mRNA and that
the decrease of PKase activity was dependent on a reduction in the level O
f M-2-PKase mRNA. Interestingly, when NaBu was removed from the culture med
ium, the levels of these mRNAs reverted to their original levels after 16 h
. During these processes, the specific activity of 5'-Nase and the level of
its mRNA remained unchanged. In contrast, when F9 cells were treated with
RA, only the level of L/B/K-type ALPase mRNA increased. Lastly, we examined
the issue of whether an increase in the level of ALPase mRNA is dependent
on the transcriptional activation of the mouse L/B/K-type ALPase gene. Tran
sient transfection assays using luciferase reporter constructs showed that
the promoter activity increased as the result of treatment with RA but not
with NaBu. Mol. Reprod. Dev. 60: 165-171, 2001. (C) 2001 Wiley-Liss, Inc.